• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于喹啉和嘧啶的肌浆网/内质网钙ATP酶变构调节剂

Quinoline- and Pyrimidine-based Allosteric Modulators of the Sarco/Endoplasmic Reticulum Calcium ATPase.

作者信息

Paula Stefan, Jahani Farnaz, Almahmodi Dina, Sobota Sydni, Devaraja Shiffany, O'Brien Nicholas S, Young Kelly A, Prichard Kate, McCluskey Adam

机构信息

Department of Chemistry, California State University Sacramento, 6000 J Street, Sacramento, CA, 95819, USA.

Chemistry, School of Environmental and Life Sciences, The University of Newcastle, University Drive, Callaghan, New South Wales, Australia.

出版信息

ChemMedChem. 2025 Mar 3;20(5):e202400763. doi: 10.1002/cmdc.202400763. Epub 2024 Nov 21.

DOI:10.1002/cmdc.202400763
PMID:39499613
Abstract

Small-molecule allosteric activators of the enzyme sarco/endoplasmic reticulum calcium ATPase (SERCA) hold promise as novel experimental tools to manipulate intracellular calcium concentrations and as therapeutic agents to treat medical conditions associated with elevated cytosolic calcium levels. Here, we synthesized and characterized 20 analogs of the known allosteric SERCA activator CDN1163 and tested their ability to stimulate SERCA activity. The structures of the compounds varied in the alkyl group of the parent scaffold's ether moiety as well as in the composition of the nitrogenous aromatic ring system. The most active compounds exhibited potencies in the sub-micromolar range while increasing enzyme activity by more than 25 %. The observed structure-activity relationships indicated that bulky alkyl groups in the ether moiety along with a quinoline ring methyl substituent were beneficial for activity. Replacement of the quinoline by a pyrimidine ring system reduced activity. To conceive a potential mechanism of action, we generated a molecular model of the transition state of SERCA when undergoing the rate-limiting step of its catalytic cycle. Subsequent blind docking with CDN1163 identified a high-affinity binding site close to the enzyme's ATP binding pocket, suggesting that the activators may accelerate SERCA's catalytic cycle by aiding in ATP binding and positioning.

摘要

肌浆网/内质网钙ATP酶(SERCA)的小分子变构激活剂有望成为操纵细胞内钙浓度的新型实验工具,以及治疗与胞质钙水平升高相关病症的治疗剂。在此,我们合成并表征了已知的SERCA变构激活剂CDN1163的20种类似物,并测试了它们刺激SERCA活性的能力。这些化合物的结构在母体支架醚部分的烷基以及含氮芳香环系统的组成上有所不同。活性最高的化合物表现出亚微摩尔范围内的效力,同时酶活性增加超过25%。观察到的构效关系表明,醚部分的庞大烷基以及喹啉环甲基取代基有利于活性。用嘧啶环系统取代喹啉会降低活性。为了构想一个潜在的机制,我们生成了SERCA在其催化循环的限速步骤中过渡态的分子模型。随后与CDN1163进行的盲对接确定了一个靠近酶ATP结合口袋的高亲和力结合位点,这表明激活剂可能通过帮助ATP结合和定位来加速SERCA的催化循环。

相似文献

1
Quinoline- and Pyrimidine-based Allosteric Modulators of the Sarco/Endoplasmic Reticulum Calcium ATPase.基于喹啉和嘧啶的肌浆网/内质网钙ATP酶变构调节剂
ChemMedChem. 2025 Mar 3;20(5):e202400763. doi: 10.1002/cmdc.202400763. Epub 2024 Nov 21.
2
Molecular determinants of sarco/endoplasmic reticulum calcium ATPase inhibition by hydroquinone-based compounds.对苯二酚类化合物抑制肌浆网/内质网钙ATP酶的分子决定因素
Proteins. 2008 Feb 15;70(3):639-49. doi: 10.1002/prot.21542.
3
The molecular determinants of calcium ATPase inhibition by curcuminoids.姜黄素类抑制钙 ATP 酶的分子决定因素。
Biochim Biophys Acta Biomembr. 2024 Oct;1866(7):184367. doi: 10.1016/j.bbamem.2024.184367. Epub 2024 Jul 3.
4
CDN1163, an activator of sarco/endoplasmic reticulum Ca ATPase, up-regulates mitochondrial functions and protects against lipotoxicity in pancreatic β-cells.CDN1163是肌浆网/内质网Ca-ATP酶的激活剂,可上调线粒体功能并保护胰腺β细胞免受脂毒性。
Br J Pharmacol. 2023 Nov;180(21):2762-2776. doi: 10.1111/bph.16160. Epub 2023 Jul 11.
5
Structural requirements for inhibitory effects of bisphenols on the activity of the sarco/endoplasmic reticulum calcium ATPase.双酚类物质对肌浆/内质网钙 ATP 酶活性抑制作用的结构要求。
Bioorg Med Chem. 2013 Jul 1;21(13):3927-33. doi: 10.1016/j.bmc.2013.04.012. Epub 2013 Apr 15.
6
Chronic pharmacological activation of SERCA with CDN1163 affects spatial cognitive flexibility but not attention and impulsivity in mice.慢性 SERCA 药理学激活剂 CDN1163 影响小鼠的空间认知灵活性,但不影响注意力和冲动性。
Behav Pharmacol. 2023 Dec 1;34(8):477-487. doi: 10.1097/FBP.0000000000000756. Epub 2023 Oct 1.
7
Conformational memory in the association of the transmembrane protein phospholamban with the sarcoplasmic reticulum calcium pump SERCA.跨膜蛋白磷酸化酶结合蛋白与肌浆网钙泵 SERCA 相互作用的构象记忆。
J Biol Chem. 2017 Dec 29;292(52):21330-21339. doi: 10.1074/jbc.M117.794453. Epub 2017 Oct 29.
8
Calcium binding and allosteric signaling mechanisms for the sarcoplasmic reticulum Ca²+ ATPase.肌浆网 Ca²⁺-ATP 酶的钙结合和变构信号机制。
Protein Sci. 2012 Oct;21(10):1429-43. doi: 10.1002/pro.2129.
9
Stimulation of Ca -ATPase Transport Activity by a Small-Molecule Drug.小分子药物对 Ca-ATPase 转运活性的刺激作用。
ChemMedChem. 2021 Nov 5;16(21):3293-3299. doi: 10.1002/cmdc.202100350. Epub 2021 Aug 26.
10
Thermodynamics of Cation Binding to the Sarcoendoplasmic Reticulum Calcium ATPase Pump and Impacts on Enzyme Function.阳离子与肌质内质网钙 ATP 酶泵的结合热力学及其对酶功能的影响。
J Chem Theory Comput. 2019 Apr 9;15(4):2692-2705. doi: 10.1021/acs.jctc.8b01312. Epub 2019 Mar 13.

引用本文的文献

1
SAR-Guided Development of Small-Molecule SERCA2a Activators: Discovery of Potent Indoline, Benzofuran, and Benzodioxole Analogs for Cardiovascular Applications.基于结构活性关系(SAR)指导的小分子肌浆网Ca2+-ATP酶2a(SERCA2a)激活剂的开发:发现用于心血管应用的强效吲哚啉、苯并呋喃和苯并二恶唑类似物。
J Med Chem. 2025 Aug 14;68(15):16306-16330. doi: 10.1021/acs.jmedchem.5c01192. Epub 2025 Jul 24.
2
Allosteric Modulation of SERCA Pumps in Health and Disease: Structural Dynamics, Posttranslational Modifications, and Therapeutic Potential.健康与疾病中肌浆网Ca2+-ATP酶泵的变构调节:结构动力学、翻译后修饰及治疗潜力
J Mol Biol. 2025 May 9:169200. doi: 10.1016/j.jmb.2025.169200.
3
Machine Learning-Driven Discovery of Structurally Related Natural Products as Activators of the Cardiac Calcium Pump SERCA2a.
机器学习驱动发现结构相关的天然产物作为心脏钙泵SERCA2a的激活剂。
ChemMedChem. 2025 May 5;20(9):e202400913. doi: 10.1002/cmdc.202400913. Epub 2025 Feb 6.